Back to search

Chemical genomics as an emerging paradigm for postgenomic drug discovery

Data up to Jan 2025

Published2003
Citations22
References45

Total Citations Per Year

Abstract

References (45)

The druggable genome

2002 • 3,099 citations

Drug Discovery: A Historical Perspective

2000 • 2,654 citations

Discovering High-Affinity Ligands for Proteins: SAR by NMR

1996 • 1,986 citations

High-Density Miniaturized Thermal Shift Assays as a General Strategy for Drug Discovery

2001 • 825 citations

Exploiting Chemical Libraries, Structure, and Genomics in the Search for Kinase Inhibitors

1998 • 792 citations

Chemosensitivity prediction by transcriptional profiling

2001 • 673 citations

Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools

2000 • 564 citations

Chemical genetics resulting from a passion for synthetic organic chemistry

1998 • 405 citations

Profiling Serine Hydrolase Activities in Complex Proteomes

2001 • 361 citations

Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness

2002 • 344 citations

Chemical Approaches for Functionally Probing the Proteome

2002 • 293 citations

PERSPECTIVE

2003 • 245 citations

A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR)

2000 • 171 citations

Chemogenomic approaches to drug discovery

2001 • 166 citations

Chemical genetic approaches for the elucidation of signaling pathways

2001 • 142 citations

Finding the next Gleevec: FLT3 targeted kinase inhibitor therapy for acute myeloid leukemia

2002 • 113 citations

Chemical genomics: Functional analysis of orphan nuclear receptors in the regulation of bile acid metabolism

2001 • 109 citations

Structure-based screening of low-affinity compounds

2002 • 108 citations

Fulfilling the promise: drug discovery in the post-genomic era

2003 • 106 citations

Structural biology in drug design: selective protein kinase inhibitors

2002 • 100 citations

Comparison of Assay Technologies for a Tyrosine Kinase Assay Generates Different Results in High Throughput Screening

2002 • 99 citations

Chemical ligands, genomics and drug discovery

2000 • 89 citations

High-diversity combinatorial libraries

2000 • 89 citations

The chemical-biological interface: developments in automated and miniaturised screening technology

1997 • 81 citations

Novel chemical genetic approaches to the discovery of signal transduction inhibitors

2002 • 81 citations

An Autosampling Differential Scanning Calorimeter Instrument for Studying Molecular Interactions

2002 • 79 citations

Minireview: Genomics Versus Orphan Nuclear Receptors—A Half-Time Report

2002 • 76 citations

Serendipity meets precision: the integration of structure-based drug design and combinatorial chemistry for efficient drug discovery

1997 • 68 citations

High-throughput chemistry and structure-based design: survival of the smartest

2001 • 61 citations

Functional cell-based uHTS in chemical genomic drug discovery

2002 • 56 citations

New drug approvals for 2002

2003 • 51 citations

HTS in the new millennium

2000 • 46 citations

Chemical Genomics: A Systematic Approach in Biological Research and Drug Discovery

2002 • 43 citations

Chemical genomics in the global study of protein functions

2002 • 41 citations

The new partnership of genomics and chemistry for accelerated drug development

1997 • 32 citations

Probes for chemical genomics by design

2002 • 31 citations

Applications of biomolecular interaction analysis in drug development

2002 • 26 citations

Targeting signal transduction with large combinatorial collections

2002 • 15 citations

Special Report: High Throughput Screening 2002: Moving Toward Increased Success Rates

2002 • 15 citations

Chemical genomics: discovery of disease genes and drugs

2002 • 11 citations

Discovery of new chemical classes of synthetic ligands that suppress neuroinflammatory responses

2002 • 8 citations

Chemogenomics – pharmacology with genomics tools

2002 • 6 citations

Finding the molecules to fuel chemogenomics

2002 • 6 citations

Turning quantity into quality: novel quality assurance strategies for data produced by high-throughput genomics technologies

2002 • 3 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...
Chemical genomics as an emerging paradigm for postgenomic drug discovery (2003) – Pharmacogenomics | Metascience Observatory Explorer